China Resources Sanjiu completes restricted share repurchase and cancellation

China Resources Sanjiu Medical & Pharmaceutical announced the completion of its restricted share repurchase and cancellation, involving a total of 36,505 shares. This represented 0.002% of the company's total share capital before the repurchase. The total capital outlay for this operation was CNY 399,686.55, affecting six individuals.

Following the cancellation, the company's total share capital decreased by 36,505 shares, from 1,664,254,363 shares to 1,664,217,858 shares. The repurchases were prompted by reasons including employees' termination of employment due to normal transfers or mutual agreement, and one employee not meeting performance targets for unlocking restricted shares.

The repurchased shares were acquired at an adjusted price of CNY 10.9488165 per share, plus bank deposit interest for a portion of the shares, using the company's own funds. This action is not expected to significantly impact the company's financial or operational results.